v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 28, 2013
Dec. 29, 2012
Dec. 31, 2011
Cash flows from operating activities:      
Net income $ 471,462 $ 423,388 $ 404,656
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Depreciation and amortization 128,035 125,322 115,896
Accelerated amortization of deferred financing costs 6,203 0 0
Loss on sale of equity investment 12,535 0 0
Stock-based compensation expense 35,527 37,313 36,932
Provision for losses on trade and other accounts receivable 5,189 4,407 6,156
Provision for (benefit from) deferred income taxes (11,514) 10,072 (19,319)
Stock issued to 401(k) plan 0 0 5,798
Equity in earnings of affiliates (10,194) (7,058) (15,561)
Distributions from equity affiliates 16,529 14,499 14,883
Other 20,790 14,193 6,352
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (45,110) (73,925) 36,204
Inventories (48,087) (193,585) (44,155)
Other current assets 15,747 (62,390) (10,493)
Accounts payable and accrued expenses 67,063 115,863 17,276
Net cash provided by (used in) operating activities 664,175 408,099 554,625
Cash flows from investing activities:      
Purchases of fixed assets (60,215) (51,237) (45,176)
Payments related to equity investments and business acquisitions, net of cash acquired (182,363) (220,238) (149,403)
Payments related to sale of equity investment (13,364) 0 0
Proceeds from sales of available-for-sale securities 0 9,225 2,600
Other (10,663) (7,354) (1,243)
Net cash provided by (used in) investing activities (266,605) (269,604) (193,222)
Cash flows from financing activities:      
Proceeds from (repayments of) bank borrowings 2,175 (32,185) 13,316
Proceeds from issuance of long-term debt 678,781 155,132 3,101
Debt issuance costs (1,372) (1,482) (2,847)
Principal payments for long-term debt (729,977) (40,722) (33,722)
Proceeds from issuance of stock upon exercise of stock options 35,553 72,485 34,519
Payments for repurchases of common stock (300,251) (299,883) (200,002)
Excess tax benefits related to stock-based compensation 8,141 17,819 8,765
Distributions to noncontrolling shareholders (19,224) (21,284) (10,055)
Acquisitions of noncontrolling interests in subsidiaries (9,800) (20,481) (170,199)
Other 0 0 (90)
Net cash provided by (used in) financing activities (335,974) (170,601) (357,214)
Effect of exchange rate changes on cash and cash equivalents 4,940 6,902 (7,253)
Net change in cash and cash equivalents 66,536 (25,204) (3,064)
Cash and cash equivalents, beginning of period 122,080 147,284 150,348
Cash and cash equivalents, end of period $ 188,616 $ 122,080 $ 147,284